These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2941817

  • 1. The effects of a 5-HT1 receptor ligand isapirone (TVX Q 7821) on 5-HT synthesis and the behavioural effects of 5-HT agonists in mice and rats.
    Goodwin GM, De Souza RJ, Green AR.
    Psychopharmacology (Berl); 1986; 89(3):382-7. PubMed ID: 2941817
    [Abstract] [Full Text] [Related]

  • 2. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 3. Effect of chronic treatment with 5-HT1 agonist (8-OH-DPAT and RU 24969) and antagonist (isapirone) drugs on the behavioural responses of mice to 5-HT1 and 5-HT2 agonists.
    De Souza RJ, Goodwin GM, Green AR, Heal DJ.
    Br J Pharmacol; 1986 Oct; 89(2):377-84. PubMed ID: 2946344
    [Abstract] [Full Text] [Related]

  • 4. The interoceptive discriminative stimuli induced by the novel putative anxiolytic TVX Q 7821: behavioral evidence for the specific involvement of serotonin 5-HT1A receptors.
    Spencer DG, Traber J.
    Psychopharmacology (Berl); 1987 Oct; 91(1):25-9. PubMed ID: 2881318
    [Abstract] [Full Text] [Related]

  • 5. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 6. The effects of Ca2+ antagonists and hydralazine on central 5-hydroxytryptamine biochemistry and function in rats and mice.
    Green AR, DeSouza RJ, Davies EM, Cross AJ.
    Br J Pharmacol; 1990 Jan 06; 99(1):41-6. PubMed ID: 1691944
    [Abstract] [Full Text] [Related]

  • 7. Involvement of 5-HT1A- and alpha 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralin.
    Marsden CA, Martin KF.
    Br J Pharmacol; 1986 Oct 06; 89(2):277-86. PubMed ID: 2430656
    [Abstract] [Full Text] [Related]

  • 8. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
    Jackson HC, Kitchen I.
    Neuropharmacology; 1989 Jun 06; 28(6):635-42. PubMed ID: 2526930
    [Abstract] [Full Text] [Related]

  • 9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 06; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory presynaptic 5-hydroxytryptamine (5-HT) receptors on the sympathetic nerves of the human saphenous vein.
    Göthert M, Kollecker P, Rohm N, Zerkowski HR.
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Apr 06; 332(4):317-23. PubMed ID: 2942782
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock.
    Heal DJ, Smith SL.
    Neuropharmacology; 1988 Dec 06; 27(12):1239-48. PubMed ID: 2977427
    [Abstract] [Full Text] [Related]

  • 13. Modulation of neuronal activity in the hippocampus by 5-hydroxytryptamine and 5-hydroxytryptamine1A selective drugs.
    Peroutka SJ, Mauk MD, Kocsis JD.
    Neuropharmacology; 1987 Dec 06; 26(2-3):139-46. PubMed ID: 2884586
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological differentiation and characterization of 5-HT1A, 5-HT1B, and 5-HT1C binding sites in rat frontal cortex.
    Peroutka SJ.
    J Neurochem; 1986 Aug 06; 47(2):529-40. PubMed ID: 2942638
    [Abstract] [Full Text] [Related]

  • 16. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E, Goldstein M, Bohmaker K.
    Mol Pharmacol; 1990 Feb 06; 37(2):231-7. PubMed ID: 1968223
    [Abstract] [Full Text] [Related]

  • 17. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J, Sugimoto Y, Horisaka K.
    Eur J Pharmacol; 1988 Sep 23; 154(3):299-304. PubMed ID: 2976671
    [Abstract] [Full Text] [Related]

  • 18. Antidepressant-like action of 5-HT1A agonists and conventional antidepressants in an animal model of depression.
    Kennett GA, Dourish CT, Curzon G.
    Eur J Pharmacol; 1987 Feb 24; 134(3):265-74. PubMed ID: 2883013
    [Abstract] [Full Text] [Related]

  • 19. The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism.
    Goodwin GM, De Souza RJ, Wood AJ, Green AR.
    Psychopharmacology (Berl); 1986 Feb 24; 90(4):488-93. PubMed ID: 2949333
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of 8-OH-DPAT-induced inhibition of rat hippocampal 5-HT release in vivo as measured by microdialysis.
    Sharp T, Bramwell SR, Hjorth S, Grahame-Smith DG.
    Br J Pharmacol; 1989 Nov 24; 98(3):989-97. PubMed ID: 2574066
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.